Immuneering Signs Clinical Supply Agreement With Regeneron To Evaluate IMM-1-104 Plus Libtayo
Immuneering Corporation (IMRX), a clinical-stage oncology company, Thursday said it has signed a clinical supply agreement with ...
Major CT company rolls out new logo in age of smartphone communication. It’s name is changing too.
The Connecticut company’s long-lived logo is now getting a new look tailored for the future and the dramatic shift to digital ...
Immuneering announces clinical supply agreement with Regeneron
Immuneering (IMRX) announced a clinical supply agreement with Regeneron Pharmaceuticals (REGN) for its anti-PD-1 therapy, Libtayo. The supply ...
Regeneron Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors despite daily gains
This was the stock's second consecutive day of gains.